Crinetics Pharmaceuticals, Inc.
CRNX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,924,055 | $2,697,429 | $3,122,641 | $4,678,088 |
| - Cash | $110,901 | $53,726 | $94,569 | $264,545 |
| + Debt | $49,144 | $49,936 | $50,819 | $51,722 |
| Enterprise Value | $3,862,298 | $2,693,639 | $3,078,891 | $4,465,265 |
| Revenue | $143 | $1,031 | $361 | $0 |
| % Growth | -86.1% | 185.6% | – | – |
| Gross Profit | -$90,321 | $1,031 | $361 | $0 |
| % Margin | -63,161.5% | 100% | 100% | – |
| EBITDA | -$129,079 | -$128,153 | -$110,480 | -$93,957 |
| % Margin | -90,265% | -12,430% | -30,603.9% | – |
| Net Income | -$130,091 | -$115,637 | -$96,774 | -$80,595 |
| % Margin | -90,972.7% | -11,216% | -26,807.2% | – |
| EPS Diluted | -1.38 | -1.23 | -1.04 | -0.88 |
| % Growth | -12.2% | -18.3% | -18.2% | – |
| Operating Cash Flow | -$110,718 | -$85,851 | -$88,452 | -$64,674 |
| Capital Expenditures | -$863 | -$3,202 | -$1,239 | -$1,029 |
| Free Cash Flow | -$111,581 | -$89,053 | -$89,691 | -$65,703 |